Fluorouracil Accord 50 mg/ml διάλυμα για ένεση/έγχυση clinical trials
4 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
A phase II randomized trial, non comparative, evaluating chemotherapy associated cisplatin, 5-fluorouracil and docetaxel at adapted doses in patients with locally advanced squamous cell carcinoma
This study looks at different chemotherapy drugs for people with a certain type of head and neck cancer that hasn't spread far. It checks how well a combination of treatments works after 8 weeks and if it helps people live longer and have a better quality of life.
For: locally advanced squamous cell carcinomaFrance - AuthorisedTherapeutic confirmatory (Phase III)
Perioperative versus adjuvant FOLFIRINOX for resectable pancreatic cancer: the PREOPANC-3 study
This study looks at treating pancreatic cancer with strong chemotherapy (FOLFIRINOX) either before or after surgery. Researchers want to see if giving it before surgery helps people live longer. It's for adults with pancreatic cancer that hasn't spread and can be removed by surgery.
For: Non-metastatic resectable pancreatic cancerNetherlands · Sweden - Ongoing, recruitingTherapeutic confirmatory (Phase III)
THE (COST)EFFECTIVENESS OF NEOADJUVANT FOLFIRINOX VERSUS NEOADJUVANT GEMCITABINE BASED CHEMORADIOTHERAPY AND ADJUVANT GEMCITABINE FOR (BORDERLINE) RESECTABLE PANCREATIC CANCER (PREOPANC-2 STUDY)
This study looks at two different ways to treat pancreatic cancer that can or might be surgically removed. It compares using a specific combination of powerful medicines before surgery to another powerful medicine combined with radiation before surgery, followed by more medicine. The main goal is to see which treatment helps people live longer.
For: non-metastatic (borderline) resectable pancreatic cancerNetherlands - AuthorisedTherapeutic exploratory (Phase II)
Neo-adjuvant intraperitoneal chemotherapy (irinotecan) and systemic chemotherapy (mFOLFOX4-bevacizumab) prior to CRS-HIPEC for patients with isolated resectable colorectal peritoneal metastases: a multicentre, phase II trial (INTERACT-PLUS)
This study looks at new ways to treat bowel cancer that has spread to the lining of the tummy. It tests a combination of medicines given before surgery to see if it helps patients. The goal is to improve treatment for this type of cancer.
For: Patients with colorectal peritoneal metastases with a PCI-score of 1-20Netherlands